HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, has appointed Ryan Atienza to Vice President of Sales, a newly created position, at its Denville Scientific subsidiary, effective February 16. Mr. Atienza will be a member of the […]

Beverly, MA — Quad Technologies Inc (“Quad”), developer of a novel separation technology, has formally announced its entry into the cell separation market. Focused on overcoming barriers associated with conventional cell purification techniques, the company boasts remarkable scientific expertise, a wealth of business experience and comprehensive financial backing. Led by visionary CEO Dr. Sean Kevlahan, […]

BOTHELL, WA — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today announced that it has commenced GMP manufacturing of low molecular weight (LMD) Dextran solutions for use in […]

München — Scientific Director Dr. Winston Shim and his research group aim at restoring compromised heart tissue by using stem cell therapies. To promote their research they recently invested in several Nanion platforms for patch clamped-based ion channel screening, characterization, and cardiotoxicity screening. The SyncroPatch 384/768PE is an advanced robotic screening platform that is used […]

MADISON, Wis.– Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that it has manufactured, under current Good Manufacturing Practices (cGMP), stem cell lines from two HLA “superdonors.” HLA superdonors are individuals whose genetic HLA (human leukocyte antigens, or HLA) profiles make their cells or tissues more compatible for donation to unrelated patients—a concern that arises […]

Stockholm and Munich — Biolin Scientific Holding AB, Sweden and Nanion Technologies GmbH, Germany today announce that the parties have entered into a licensing agreement. Biolin Scientific has agreed to grant a non-exclusive license for the key patent related to performing multi-hole, high-throughput ion channel screening to Nanion Technologies in exchange for an undisclosed license […]

SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced that Science for Life Laboratory (SciLifeLab) has established the Swedish National Center for Single-Cell Biology. The center features six C1TM systems, three CyTOF® 2 systems and a BiomarkTM HD system, making SciLifeLab one of the preeminent users of the full line of Fluidigm’s single-cell technologies […]

Berlin, Germany -– BioGenes GmbH, a global leader in host cell protein (HCP) assay development, today announced that it has signed long-term agreements with distributors in USA and Canada, India, Japan and Middle/South America to offer its enhanced generic HCP assay CHO|360-HCP ELISA within their respective territories. Europe and the rest of world (ROW) will […]

SAN DIEGO, California — ACEA Biosciences, Inc., a pioneer in the development and commercialization of high performance, cutting edge cell analysis platforms for life science research, is pleased to announce Michael Honeysett as Vice President of Global Commercialization. Mike Honeysett is a seasoned executive in the life science cellular analysis industry. He has created significant […]

Biolin Scientific today announces the acquisition of a key patent related to performing multi-hole, high-throughput ion channel screening. “We are pleased to strengthen our position as the leaders in high-throughput ion channel screening and this patent, along with Sophion Qube™, our new instrument platform for high-through put screening, will enable us to screen hundreds of […]